Abstract
Antibodies, mainly monoclonal, represent important tools for therapy and diagnosis, due to their high specificity towards the antigen. The studies with monoclonal antibodies started in the 70's when the hybridoma technology was devised. It meant, in subsequent years, a leap in understanding, monitoring and treating of many infections and pathologies. Notwithstanding, in several cases, onl…